Place · Level 3
Respiratory System
3 亿肺泡 · 70 m² 交换面 · 每天 20000 次呼吸 ~ 12000 L 空气 · O₂/CO₂ + 酸碱 + 高原 HIF + 氧感受诺贝尔奖通路
Last updated
Story path
- 1300 M alveoli · 70 m² exchange300 M alveoli · 70 m² exchange
- 2Gas exchange · 0.25 sGas exchange · 0.25 s
- 3Acid-base · lung + kidney duetAcid-base · lung + kidney duet
- 4Altitude + HIF · oxygen-sensing NobelAltitude + HIF · oxygen-sensing Nobel
- 5COPD + asthma · what nutrition doesCOPD + asthma · what nutrition does
- 6Breathing patterns + trainingBreathing patterns + training
Chapter 1
300 M alveoli · 70 m² exchange
300 M alveoli · 70 m² exchange
The lung looks like a pair of fleshy blocks, but is actually a carefully folded tree — its total leaf-area is about 70 m² (roughly a tennis court), all packed inside your chest.
Lung geometry (Weibel 1963 classic measurement):
Airway branching: trachea → bronchus → 23 generations of bifurcation → 300 million alveoliAlveolus diameter ~0.2 mm, wall thickness ~0.5 μm (100× thinner than a hair)Total exchange surface ~70 m² (some estimates reach 100 m²; 70 is commonly cited)Total pulmonary capillary length ~1000 km — about 1/4 of all body capillaries are in the lungs
This design is up against physical limits: thin enough that any thinner would rupture, but any thicker would block diffusion (Fick's law has diffusion rate proportional to area / thickness); large enough that any larger wouldn't fit in the chest, but any smaller wouldn't keep up with cardiac output.
A day's workload: resting respiratory rate 12-16 breaths/min, ~20,000 breaths/day; resting tidal volume ~500 mL, ~12 m³ of air per day (about 1/5 of a bedroom); during exercise minute ventilation can spike 25× to 200 L/min.
The body has only two direct conduits to the outside world — the respiratory tract and the GI tract. The GI tract is relatively short, with mucus, gastric acid, and the liver layer-filtering it. The respiratory tract is directly exposed to ambient air — PM2.5, smoke, viruses, allergens — and is guarded by mucus + cilia + alveolar macrophages + IgA + antimicrobial peptides. This is why the vitamin-D / vitamin-A / zinc immune stories in the atlas land most directly here, in the respiratory tract.
Lung geometry (Weibel 1963 classic measurement):
Airway branching: trachea → bronchus → 23 generations of bifurcation → 300 million alveoliAlveolus diameter ~0.2 mm, wall thickness ~0.5 μm (100× thinner than a hair)Total exchange surface ~70 m² (some estimates reach 100 m²; 70 is commonly cited)Total pulmonary capillary length ~1000 km — about 1/4 of all body capillaries are in the lungs
This design is up against physical limits: thin enough that any thinner would rupture, but any thicker would block diffusion (Fick's law has diffusion rate proportional to area / thickness); large enough that any larger wouldn't fit in the chest, but any smaller wouldn't keep up with cardiac output.
A day's workload: resting respiratory rate 12-16 breaths/min, ~20,000 breaths/day; resting tidal volume ~500 mL, ~12 m³ of air per day (about 1/5 of a bedroom); during exercise minute ventilation can spike 25× to 200 L/min.
The body has only two direct conduits to the outside world — the respiratory tract and the GI tract. The GI tract is relatively short, with mucus, gastric acid, and the liver layer-filtering it. The respiratory tract is directly exposed to ambient air — PM2.5, smoke, viruses, allergens — and is guarded by mucus + cilia + alveolar macrophages + IgA + antimicrobial peptides. This is why the vitamin-D / vitamin-A / zinc immune stories in the atlas land most directly here, in the respiratory tract.
肺的几何 · Weibel 经典测量
肺的几何 (Weibel 1963 经典测量):气道分级: 气管 → 支气管 → 23 级分叉 → 3 亿肺泡 (alveoli)肺泡直径约 0.2 mm, 壁厚约 0.5 μm (比一根头发细 100 倍)总交换面约 70 m² (有研究估到 100 m², 但通常引用 70)肺毛细血管总长约 1000 km — 体内总毛细血管约 1/4 在肺
这套设计逼近物理极限: 再薄就会破裂, 太厚就扩散不动 (Fick 定律里扩散速率正比于面积除以厚度); 再大就装不进胸腔, 太小就跟不上心输出。
Mucus · cilia · macrophages — the 3 gates
Why you aren't overwhelmed by airborne viruses and particulates — three gatekeepers work 24/7.Gate 1: Mucus + mucociliary escalator. Goblet cells secrete mucus, about 100 mL/day; each epithelial cell has about 200 cilia on its apical surface beating 12-15 times per second, pushing mucus and trapped particles up to the throat, where it gets swallowed and killed by stomach acid. Smoking paralyzes cilia — 1 hour of smoke paralyzes them for 6 hours; long-term smoking leads to permanent ciliary dysfunction, mucus accumulation, and recurrent infection (the chemical root of chronic bronchitis). Cystic fibrosis is a CFTR mutation that makes mucus too thick for cilia to push, with recurrent lung infections and average lifespan around 40.
Gate 2: Alveolar macrophages. They patrol the inner alveolar surface, engulfing particles, apoptotic cells, and pathogens that get past the mucus layer. Smokers have 4-6× more alveolar macrophages than normal, but their function is impaired. Vitamin D upregulates the macrophage antimicrobial peptide LL-37 (see vitamin-d/immune L4). Engulfed-clogged alveolar macrophages are called dust cells — the black lung seen at autopsy in long-term smokers is exactly that (dust + tar).
Gate 3: Mucosal immunity. Secretory IgA (sIgA) is the main mucosal immunoglobulin, blocking virus binding to epithelium; when vitamin A / D are adequate, sIgA is supported. Antimicrobial peptides LL-37 (cathelicidin) and β-defensin are upregulated by vitamin D and directly puncture bacterial membranes. IgE and mast cells run the allergy pathway, the main line in asthma.
So 'eat more fruit for immunity' for respiratory infection — 99% of the real benefit goes through this line: when vitamin C + vitamin D + zinc are adequate, mucus quality, ciliary motion, antimicrobial peptides, and IgA all benefit; it isn't 'killing viruses', it's 'making this door stronger'. This is the mechanistic root behind the Martineau 2017 vitamin D meta, which reports a single overall OR of 0.88 (95% CI 0.81-0.96) — about a 12% reduction — with the largest effect (OR 0.30) in those severely deficient at baseline.
martineau-2017
Chapter 2
Gas exchange · 0.25 s
Gas exchange · 0.25 s
A red blood cell takes about 0.75 seconds to traverse a pulmonary capillary, but O₂/CO₂ exchange completes in about 0.25 seconds — that buffer is the lung's most important safety margin.
Fick diffusion law: V_gas = (D × A × ΔP) / T, where D is the gas diffusion constant (CO₂ is 20× higher than O₂, which is why CO₂ retention is hard but oxygenation failure is easy); A is the 70 m² exchange surface; ΔP is the alveolar-blood partial pressure gradient; T is the alveolar-capillary membrane thickness, about 0.5 μm.
Normal partial pressures (resting, sea level): alveolar O₂ (PAO₂) ~100 mmHg; arterial O₂ (PaO₂) ~95-100 mmHg, about 5 mmHg below PAO₂ (A-a gradient, the clinical diffusion test); venous O₂ ~40 mmHg (tissues use about 60 mmHg, the price of adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it. generation); CO₂ ~40 in alveolus, ~40 arterial, ~46 venous.
Hemoglobin is the real protagonist. Oxygen has extremely low solubility in plasma — without Hb, 100 mmHg O₂ only gives 0.3 mL/100 mL blood; with Hb, oxygen carrying capacity is about 20 mL/100 mL blood — about 70× more. Hb's cooperative S-shaped binding curve plus the Bohr effect lets lungs load and tissues release. See iron/red-cells L4 for the full Bohr-effect animation.
Breathing is not the same as oxygenation. Hypoxia roughly comes in 4 types:
1. Hypoxic: low alveolar O₂ — altitude / COPD / pulmonary fibrosis
2. Anemic: not enough Hb to carry — iron deficiency / B12 deficiency / carbon monoxide poisoning
3. Stagnant: heart failure / shock / thrombus
4. Histotoxic: cyanide poisoning — cells can't use O₂
Measuring SpO₂ only catches type 1; in types 2-4 SpO₂ may look normal while the person is hypoxic. In CO poisoning SpO₂ is falsely normal — CO binding to Hb makes the fingertip pulse oximeter inaccurate; this is a real emergency, and on suspicion you must get to the ER immediately for co-oximetry.
Fick diffusion law: V_gas = (D × A × ΔP) / T, where D is the gas diffusion constant (CO₂ is 20× higher than O₂, which is why CO₂ retention is hard but oxygenation failure is easy); A is the 70 m² exchange surface; ΔP is the alveolar-blood partial pressure gradient; T is the alveolar-capillary membrane thickness, about 0.5 μm.
Normal partial pressures (resting, sea level): alveolar O₂ (PAO₂) ~100 mmHg; arterial O₂ (PaO₂) ~95-100 mmHg, about 5 mmHg below PAO₂ (A-a gradient, the clinical diffusion test); venous O₂ ~40 mmHg (tissues use about 60 mmHg, the price of adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it. generation); CO₂ ~40 in alveolus, ~40 arterial, ~46 venous.
Hemoglobin is the real protagonist. Oxygen has extremely low solubility in plasma — without Hb, 100 mmHg O₂ only gives 0.3 mL/100 mL blood; with Hb, oxygen carrying capacity is about 20 mL/100 mL blood — about 70× more. Hb's cooperative S-shaped binding curve plus the Bohr effect lets lungs load and tissues release. See iron/red-cells L4 for the full Bohr-effect animation.
Breathing is not the same as oxygenation. Hypoxia roughly comes in 4 types:
1. Hypoxic: low alveolar O₂ — altitude / COPD / pulmonary fibrosis
2. Anemic: not enough Hb to carry — iron deficiency / B12 deficiency / carbon monoxide poisoning
3. Stagnant: heart failure / shock / thrombus
4. Histotoxic: cyanide poisoning — cells can't use O₂
Measuring SpO₂ only catches type 1; in types 2-4 SpO₂ may look normal while the person is hypoxic. In CO poisoning SpO₂ is falsely normal — CO binding to Hb makes the fingertip pulse oximeter inaccurate; this is a real emergency, and on suspicion you must get to the ER immediately for co-oximetry.
V/Q matching · why the lung zones air and blood
70 m² of exchange surface still isn't enough — what matters is that the air reaching an alveolus (ventilation, V) and the blood flowing past it (perfusion, Q) line up in the same place. Physiologists call this V/Q matching, and it explains many seemingly odd clinical findings.Ideally V/Q ≈ 0.8 — about 4 L/min ventilation paired with about 5 L/min perfusion. But the lung isn't uniform:
The apex (standing) has low ventilation and perfusion, but perfusion is lower still, so V/Q runs high, approaching dead spaceThe base has more of both, but perfusion is even greater, so V/Q runs low, approaching shunt
Each extreme maps to a class of failure. Ventilation without perfusion (V/Q → infinity) is dead space, classically pulmonary embolism — a clot blocks the pulmonary artery, so that lung still breathes but no blood passes and no gas is exchanged. Perfusion without ventilation (V/Q → 0) is shunt, classically pneumonia or pulmonary edema — alveoli fill with pus or water, so blood passes but can't pick up oxygen. The trouble with shunt is that simply raising inspired oxygen often can't rescue it, because the problem isn't too little oxygen — it's that blood never reaches an alveolus that can do the exchange.
The lung has one trick for this: hypoxic pulmonary vasoconstriction (HPV). When an alveolus has low oxygen, the local pulmonary arteriole actively constricts, diverting blood to better-ventilated regions — effectively steering blood toward the rooms with open windows. This is a reaction unique to the pulmonary circulation (systemic vessels dilate under hypoxia; pulmonary ones constrict). The cost: at altitude when the whole lung is hypoxic, all the vessels constrict together, pulmonary artery pressure spikes, and over time this strains the right heart — part of the mechanism behind chronic mountain sickness and HAPE.
定量看气体交换 · Fick 定律、分压、Hb 携氧、缺氧分型
Fick 扩散定律: V_gas = (D × A × ΔP) / T. 其中 D 是气体扩散常数 (CO₂ 比 O₂ 高 20 倍, 这就是为什么 CO₂ 蓄积难, 但氧合不足易); A 是 70 m² 交换面; ΔP 是肺泡-血液气体分压差; T 是肺泡-毛细血管膜厚度, 约 0.5 μm.正常分压 (静息海平面): 肺泡里的氧约 100 mmHg, 流出来的动脉血里约 95-100 mmHg, 两者几乎相等——差的那一点点 (约 5 mmHg) 叫 A-a 差, 临床用它判断弥散功能; 静脉氧约 40 mmHg (组织用掉约 60 mmHg, 是 adenosine triphosphate: The cell's universal energy currency — almost everything that costs energy spends it. 生成的代价); CO₂ 在肺泡约 40, 动脉约 40, 静脉约 46.
氧气在血浆里溶解度极低 — 没有 Hb 时, 100 mmHg O₂ 只有 0.3 mL/100 mL 血; 加上 Hb 后, 携氧量约 20 mL/100 mL 血, 约 70 倍。Hb 协同结合曲线 (S 形) 加 Bohr 效应让肺装满、组织释放。
呼吸不等于氧合。缺氧 (hypoxia) 大致 4 类:
1. 低氧性 (hypoxic): 肺泡 O₂ 低, 如高原 / COPD / 肺纤维化
2. 贫血性 (anemic): Hb 不够运, 如缺铁 / B12 缺、一氧化碳中毒
3. 循环性 (stagnant): 心衰、休克、血栓
4. 组织性 (histotoxic): 氰化物毒, 细胞不能用 O₂
测血氧饱和度 (SpO₂) 只能识别第 1 类, 第 2-4 类 SpO₂ 可能正常但人在缺氧。CO 中毒时 SpO₂ 假性正常 — 因为 CO 与 Hb 结合让指夹脉氧读数不准, 这是真急症, 怀疑必须立即就医并用 co-oximetry 测。
Chapter 3
Acid-base · lung + kidney duet
Acid-base · lung + kidney duet
Blood pH must stay between 7.35 and 7.45 — a terrifyingly narrow window; outside 6.8-7.8 is lethal. Maintaining it depends on three buffer systems and two excretory organs.
Three buffer systems:
1. Bicarbonate buffer (HCO₃⁻ / H₂CO₃) — the dominant buffer, accounting for ~65% of blood buffering capacity. The equation is CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻, catalyzed inside red cells by carbonic anhydrase (CA); the reaction is reversible.
2. Hemoglobin buffer — histidine residues on Hb directly accept H⁺.
3. Phosphate buffer — important intracellularly and in urine; weaker in plasma.
Two excretory organs:
The lung excretes CO₂ which equals excreting acid, regulated in minutes to hours; hyperventilation drops PCO₂ and raises pH (respiratory alkalosis), seen in anxiety / panic / hyperventilation; hypoventilation raises PCO₂ and drops pH (respiratory acidosis), seen in COPD / opioid overdose / sedative overdoseThe kidney excretes H⁺ and reabsorbs HCO₃⁻, regulated over 24-48 hours; chronic CKD / distal renal tubular acidosis cause metabolic acidosis; massive vomiting loses HCl and causes metabolic alkalosis
The dual-organ design is complementary: lungs respond quickly to acute events, kidneys complete homeostasis for chronic imbalance.
Common clinical 4-type acid-base disturbances:
'Alkaline body' and 'alkaline water' are marketing concepts. Point by point: blood pH is strictly locked at 7.35-7.45 by this system; nothing you eat moves the number 1%, and if it did move you'd be sick. 'Alkaline foods' (vegetables and fruit) genuinely help — but because of potassium, magnesium, antioxidants, and fiber, not because they 'alkalinize blood'. 'Drinking baking soda water lowers uric acid' has limited benefit for acute gout (it alkalinizes urine), but the action is local urinary alkalinization, not alkalinizing blood. '«Acidic body» causes cancer' is a 2000s Chinese-internet myth that science has never supported.
Three buffer systems:
1. Bicarbonate buffer (HCO₃⁻ / H₂CO₃) — the dominant buffer, accounting for ~65% of blood buffering capacity. The equation is CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻, catalyzed inside red cells by carbonic anhydrase (CA); the reaction is reversible.
2. Hemoglobin buffer — histidine residues on Hb directly accept H⁺.
3. Phosphate buffer — important intracellularly and in urine; weaker in plasma.
Two excretory organs:
The lung excretes CO₂ which equals excreting acid, regulated in minutes to hours; hyperventilation drops PCO₂ and raises pH (respiratory alkalosis), seen in anxiety / panic / hyperventilation; hypoventilation raises PCO₂ and drops pH (respiratory acidosis), seen in COPD / opioid overdose / sedative overdoseThe kidney excretes H⁺ and reabsorbs HCO₃⁻, regulated over 24-48 hours; chronic CKD / distal renal tubular acidosis cause metabolic acidosis; massive vomiting loses HCl and causes metabolic alkalosis
The dual-organ design is complementary: lungs respond quickly to acute events, kidneys complete homeostasis for chronic imbalance.
Common clinical 4-type acid-base disturbances:
| Type | pH | PCO₂ | HCO₃⁻ | Classic cause |
|---|---|---|---|---|
| Respiratory acidosis | ↓ | ↑ | compensatory ↑ | COPD / sedative overdose |
| Respiratory alkalosis | ↑ | ↓ | compensatory ↓ | hyperventilation / altitude / pregnancy |
| Metabolic acidosis | ↓ | compensatory ↓ | ↓ | DKA / lactic acidosis / CKD / diarrhea |
| Metabolic alkalosis | ↑ | compensatory ↑ | ↑ | vomiting / diuretics / Cushing |
'Alkaline body' and 'alkaline water' are marketing concepts. Point by point: blood pH is strictly locked at 7.35-7.45 by this system; nothing you eat moves the number 1%, and if it did move you'd be sick. 'Alkaline foods' (vegetables and fruit) genuinely help — but because of potassium, magnesium, antioxidants, and fiber, not because they 'alkalinize blood'. 'Drinking baking soda water lowers uric acid' has limited benefit for acute gout (it alkalinizes urine), but the action is local urinary alkalinization, not alkalinizing blood. '«Acidic body» causes cancer' is a 2000s Chinese-internet myth that science has never supported.
Who runs breathing · diaphragm + chemoreceptors
Breathing looks automatic, but it's one of the few bodily actions that is both automatic and voluntarily controllable — behind that is a clearly divided command system.Among the working muscles, the diaphragm does about 70% of the effort. It's a dome-shaped sheet that descends when it contracts, enlarging the chest, so the lungs passively expand and air comes in; when it relaxes it springs back, and the lung's own elastic recoil pushes air out — which is why quiet exhalation costs almost no energy. The external intercostals help lift the ribs; only during forceful breathing do the accessory muscles in the neck (scalenes, sternocleidomastoid) join in — which is why people in respiratory distress shrug and strain through the neck. The diaphragm is innervated by the phrenic nerve (C3–C5), so a high cervical spinal injury can directly paralyze breathing, one of the most lethal forms of spinal cord injury.
The command center sits in the brainstem (medulla + pons), which sets the basic breathing rhythm and then adjusts it from two sets of sensors:
Central chemoreceptors (medulla): sense cerebrospinal-fluid H⁺, i.e. indirectly sense CO₂. This is the main signal regulating breathing normally — a tiny rise in CO₂ markedly increases ventilation, sensitive almost in real timePeripheral chemoreceptors (carotid + aortic bodies): mainly sense O₂, but only really kick in once PaO₂ falls below about 60 mmHg
So a counterintuitive fact: what drives your breathing normally isn't lack of oxygen, it's CO₂. This brings a clinical caution — in a minority of severe COPD patients with chronic CO₂ retention, the center has become desensitized to CO₂ and switches to hypoxic drive (driven by low oxygen). Giving these patients uncontrolled high-flow oxygen can actually suppress breathing and let CO₂ climb further — an evidence-based reason for cautious oxygen use, not hearsay.
Chapter 4
Altitude + HIF · oxygen-sensing Nobel
Altitude + HIF · oxygen-sensing Nobel
The 2019 Nobel Prize in Physiology / Medicine went to Kaelin / Ratcliffe / Semenza for solving 'how cells sense oxygen' — the most recent Nobel relevant to the atlas, and the shared molecular foundation of the EPO story, altitude adaptation, modern anti-anemia drugs, and some anti-cancer therapies.
The HIF (Hypoxia-Inducible Factor) pathway (illustrated in detail in the L4 animation):
Under normoxia, HIF-α is hydroxylated at two proline sites by prolyl hydroxylase (PHD), using O₂ as substrate — oxygen itself is the switch; the hydroxylated HIF-α is recognized by the tumor suppressor VHL, polyubiquitinated, and degraded by the proteasome; the half-life is <5 minutes, so it's continuously destroyed.
Under hypoxia, O₂ is insufficient, the PHD reaction can't run, HIF-α isn't hydroxylated, VHL can't grab it, and HIF-α stabilizes and accumulates; it enters the nucleus, dimerizes with HIF-β, binds HRE, and transcribes about 100 hypoxia-response genes — EPO (red cell production), VEGF (angiogenesis), glycolytic enzymes, iron metabolism, hypoxia-tolerance pathways. The result is upregulation of red cells, blood vessels, glycolysis, and iron utilization — switching tissue oxygen supply and use into 'hypoxia mode'.
Clinical applications are one of the cleanest mechanism-to-drug paths in the atlas:
HIF-PHI (hypoxia-inducible factor prolyl-hydroxylase inhibitors) — roxadustat / daprodustat / vadadustat: oral drugs that mimic hypoxia, stabilize HIF, induce endogenous EPO secretion, and improve iron utilization; a new option for CKD anemia; first launched in China in 2019, daprodustat received FDA approval in 2023; equally effective as injected EPO, but oral and improves iron absorption; cardiovascular safety remains debatedAnti-cancer — some renal clear cell carcinoma / pheochromocytoma carry VHL mutations, which permanently activate HIF, drive angiogenesis, and form tumors; the HIF-2α inhibitor belzutifan was FDA-approved in 2021 for VHL syndromeExercise performance and altitude training — 'live high, train low' uses sustained low oxygen to drive HIF and EPO; doing it repeatedly is doping
The HIF (Hypoxia-Inducible Factor) pathway (illustrated in detail in the L4 animation):
Under normoxia, HIF-α is hydroxylated at two proline sites by prolyl hydroxylase (PHD), using O₂ as substrate — oxygen itself is the switch; the hydroxylated HIF-α is recognized by the tumor suppressor VHL, polyubiquitinated, and degraded by the proteasome; the half-life is <5 minutes, so it's continuously destroyed.
Under hypoxia, O₂ is insufficient, the PHD reaction can't run, HIF-α isn't hydroxylated, VHL can't grab it, and HIF-α stabilizes and accumulates; it enters the nucleus, dimerizes with HIF-β, binds HRE, and transcribes about 100 hypoxia-response genes — EPO (red cell production), VEGF (angiogenesis), glycolytic enzymes, iron metabolism, hypoxia-tolerance pathways. The result is upregulation of red cells, blood vessels, glycolysis, and iron utilization — switching tissue oxygen supply and use into 'hypoxia mode'.
Clinical applications are one of the cleanest mechanism-to-drug paths in the atlas:
HIF-PHI (hypoxia-inducible factor prolyl-hydroxylase inhibitors) — roxadustat / daprodustat / vadadustat: oral drugs that mimic hypoxia, stabilize HIF, induce endogenous EPO secretion, and improve iron utilization; a new option for CKD anemia; first launched in China in 2019, daprodustat received FDA approval in 2023; equally effective as injected EPO, but oral and improves iron absorption; cardiovascular safety remains debatedAnti-cancer — some renal clear cell carcinoma / pheochromocytoma carry VHL mutations, which permanently activate HIF, drive angiogenesis, and form tumors; the HIF-2α inhibitor belzutifan was FDA-approved in 2021 for VHL syndromeExercise performance and altitude training — 'live high, train low' uses sustained low oxygen to drive HIF and EPO; doing it repeatedly is doping
Tibetan vs Andean adaptation
Altitude adaptation isn't one thing — different populations evolved different solutions; this is one of the most beautiful pieces of evidence of human biodiversity in the atlas.Tibetan plateau (average altitude ~4000 m, inhabited for ~30,000 years): the EPAS1 (= HIF-2α) gene has unique variants (Yi 2010 *Science*, 50 exome sequencing); the result is *not* a significant rise in hemoglobin but optimized oxygen utilization, improved nitric oxide: A small signal molecule from the vessel lining that relaxes the vessel-wall muscle so the vessel widens. pathway, and increased pulmonary vasodilation; some variants are shared with Denisovans, a gift from modern-human × archaic-human admixture 50,000 years ago.
Andean (Peru / Bolivia, inhabited ~12,000 years): takes the classic route — Hb is significantly elevated (~20-22 g/dL vs ~14 at sea level), with increased blood volume and hematocrit ratio. The cost is that blood becomes too thick, raising risk for chronic mountain sickness (CMS), presenting as high-altitude erythrocytosis.
Ethiopian (Amhara highlands, ~3500 m) takes yet another solution — Hb isn't significantly elevated, and there's no obvious improvement in oxygen utilization either; the mechanism isn't fully clear and involves different genes (BHLHE41, CBARA1, etc.).
The acute altitude adaptation process for a short-term lowlander going up: within hours, ventilation rises, CO₂ excretion rises, respiratory alkalosis develops, compensated by renal HCO₃⁻ excretion (3-5 days); within days, 2,3-BPG rises, the Hb-O₂ curve shifts right, tissues get O₂ more easily; within 1-2 weeks, HIF stabilizes, EPO rises, red cell production rises, and at 2-3 weeks Hb is noticeably higher. Altitude training (live high, train low) exploits this two-week window.
Acute mountain sickness (AMS): rapid ascent above 3000 m → headache, nausea, insomnia within 24-48 hours. HACE (high-altitude cerebral edema) and HAPE (high-altitude pulmonary edema) are real emergencies — without descent and treatment within hours patients can die or sustain irreversible damage; immediate descent to lower altitude and medical care are required. Prevention: slow ascent (≤500 m/day) plus acetazolamide (Diamox) started 24 hours ahead (a carbonic anhydrase inhibitor that produces metabolic acidosis to offset respiratory alkalosis and speed renal compensation). 'Tibetan altitude pills' are mostly gimmicks; real evidence-based options are acetazolamide plus dexamethasone (rescue).
yi-2010-tibet-epas1beall-2010-tibetan
Chapter 5
COPD + asthma · what nutrition does
COPD + asthma · what nutrition does
Chronic obstructive pulmonary disease (COPD) and asthma — the former is the world's 3rd leading cause of death (WHO 2024); the latter affects 350 million people. Their nutrition relationships are very different.
COPD (chronic bronchitis + emphysema) is caused 80-90% by smoking, plus indoor pollution (cooking smoke, coal) and occupational dust; α-1 antitrypsin deficiency accounts for 1-5% of cases — young people with COPD should be tested. The mechanism is long-term oxidative stress plus elastase / anti-elastase imbalance, destroying alveolar walls and forming emphysema. Clinically: barrel chest, pursed-lip breathing, chronic hypoxia.
COPD nutritional interventions with RCT evidence:
Quitting smoking: the only 'nutritional' intervention that slows COPD progression (calling it 'nutrition' is a stretch, but the benefit is 100× any supplement)Maintaining weight and preventing muscle loss: Sin 2006 + GOLD 2024 show 25-40% of COPD patients have sarcopenia + cachexia, an independent mortality predictor; key is protein 1.2-1.5 g/kg plus resistance trainingVitamin D: only in patients severely deficient at baseline does supplementation reduce moderate-severe exacerbations — overall it does nothing (Jolliffe **2019 *Thorax* IPD meta, aIRR 0.94, 95% CI 0.78-1.13; benefit confined to baseline 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. < 25 nmol/L). ⚠️ The site used to hang this on Jolliffe 2017 *Lancet Respir Med*, which is the asthma** metaNAC: oral 600-1200 mg/day long-term reduces mucus and exacerbations (Cazzola 2015 *ERR* meta), one of NAC's B-grade clinical tracksOmega-3: weakly anti-inflammatory, not first-line for COPDOxygen therapy: long-term home oxygen significantly extends life in severely hypoxic patients (NOTT 1980, MRC 1981); outside nutrition but often discussed together
Asthma is chronic eosinophilic airway inflammation + airway hyperreactivity + reversible airflow limitation, driven by the TH2 and IgE pathways; together with allergy / rhinitis / eczema it forms the atopic triad.
Asthma nutritional interventions:
Vitamin D: the Jolliffe 2017 *Lancet Respir Med* IPD meta shows supplementation cuts asthma exacerbations requiring systemic steroids by about 26% (aIRR 0.74, 95% CI 0.56-0.97); but it did not establish that deficient patients benefit more — the baseline-stratified interaction test was not significantAllergen avoidance — dust mites, pets, smokeOmega-3 / Mediterranean diet: weak effect, not first-line'Lung-protecting food restriction': unless a real allergen is identified, most lack evidence support and can cause kids to be short on protein, calcium, and zinc, leading to developmental undernutrition
Practical PM2.5 / smog defense checklist (based on Burnett 2018):
Indoor HEPA air purifier (B-grade clinical evidence, reduces CV + respiratory events)Outdoor N95 / KN95 mask (~95% PM2.5 protection); ordinary surgical masks offer essentially no PM2.5 protectionDiet: adequate vitamin C, vitamin E, carotenoids, and polyphenols (vegetables, fruit, tea) — weak but reasonable'Lung-cleansing supplements' (luo han guo + pear paste) have no RCT evidence; drinking more water to thin mucus is real, but isn't 'cleansing the lung'
COPD (chronic bronchitis + emphysema) is caused 80-90% by smoking, plus indoor pollution (cooking smoke, coal) and occupational dust; α-1 antitrypsin deficiency accounts for 1-5% of cases — young people with COPD should be tested. The mechanism is long-term oxidative stress plus elastase / anti-elastase imbalance, destroying alveolar walls and forming emphysema. Clinically: barrel chest, pursed-lip breathing, chronic hypoxia.
COPD nutritional interventions with RCT evidence:
Quitting smoking: the only 'nutritional' intervention that slows COPD progression (calling it 'nutrition' is a stretch, but the benefit is 100× any supplement)Maintaining weight and preventing muscle loss: Sin 2006 + GOLD 2024 show 25-40% of COPD patients have sarcopenia + cachexia, an independent mortality predictor; key is protein 1.2-1.5 g/kg plus resistance trainingVitamin D: only in patients severely deficient at baseline does supplementation reduce moderate-severe exacerbations — overall it does nothing (Jolliffe **2019 *Thorax* IPD meta, aIRR 0.94, 95% CI 0.78-1.13; benefit confined to baseline 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. < 25 nmol/L). ⚠️ The site used to hang this on Jolliffe 2017 *Lancet Respir Med*, which is the asthma** metaNAC: oral 600-1200 mg/day long-term reduces mucus and exacerbations (Cazzola 2015 *ERR* meta), one of NAC's B-grade clinical tracksOmega-3: weakly anti-inflammatory, not first-line for COPDOxygen therapy: long-term home oxygen significantly extends life in severely hypoxic patients (NOTT 1980, MRC 1981); outside nutrition but often discussed together
Asthma is chronic eosinophilic airway inflammation + airway hyperreactivity + reversible airflow limitation, driven by the TH2 and IgE pathways; together with allergy / rhinitis / eczema it forms the atopic triad.
Asthma nutritional interventions:
Vitamin D: the Jolliffe 2017 *Lancet Respir Med* IPD meta shows supplementation cuts asthma exacerbations requiring systemic steroids by about 26% (aIRR 0.74, 95% CI 0.56-0.97); but it did not establish that deficient patients benefit more — the baseline-stratified interaction test was not significantAllergen avoidance — dust mites, pets, smokeOmega-3 / Mediterranean diet: weak effect, not first-line'Lung-protecting food restriction': unless a real allergen is identified, most lack evidence support and can cause kids to be short on protein, calcium, and zinc, leading to developmental undernutrition
Practical PM2.5 / smog defense checklist (based on Burnett 2018):
Indoor HEPA air purifier (B-grade clinical evidence, reduces CV + respiratory events)Outdoor N95 / KN95 mask (~95% PM2.5 protection); ordinary surgical masks offer essentially no PM2.5 protectionDiet: adequate vitamin C, vitamin E, carotenoids, and polyphenols (vegetables, fruit, tea) — weak but reasonable'Lung-cleansing supplements' (luo han guo + pear paste) have no RCT evidence; drinking more water to thin mucus is real, but isn't 'cleansing the lung'
Where nutrition really touches the lung — and why 'lung cleanse' is a non-question
Lay out the relationship between nutrition and the lung, and the lines with real mechanism and evidence are few — the rest is mostly packaging.The first is immune defense. As the alveoli scene covered, the airway's three gates (mucociliary, alveolar macrophages, mucosal immunity) are all nutrition-supported: vitamin A maintains normal airway epithelial differentiation and mucus quality, and in deficiency the epithelium keratinizes and cilia thin out — a classic nutritional pathway behind childhood respiratory infection in the developing world; vitamin D upregulates the macrophage antimicrobial peptide LL-37, and the Martineau 2017 meta found that supplementing deficient people reduces acute respiratory infections overall. The logic of this line is always to make the door stronger, not to kill viruses.
The second is antioxidant tissue protection. The lung faces oxygen and pollution daily and is one of the body's most oxidatively stressed organs. Vitamin C, vitamin E, and carotenoids form the lung's antioxidant network, and epidemiologically, populations with adequate dietary antioxidants show slightly slower lung-function (FEV1) decline. But keep the proportions right: this is a weak dietary-pattern effect, not a case for megadose single supplements — high-dose β-carotene in smokers actually raised lung cancer risk (see vitamin-a / supplements), the classic counterexample of antioxidants overshooting into harm.
The third is NAC (N-acetylcysteine). It's a glutathione precursor and also directly breaks the disulfide bonds in mucus to thin phlegm. The Cazzola 2015 meta shows long-term oral 600–1200 mg/day reduces COPD exacerbations — one of the few nutrition-adjacent substances with B-grade evidence in pulmonology.
Back to 'cleansing the lung'. The phrase assumes the lung holds dirt that can be flushed or expelled, but lung cleaning runs on the mucociliary escalator pushing particles up to be swallowed, plus alveolar macrophages engulfing inhaled matter and slowly metabolizing it — a built-in continuous process that no food, tea, or supplement can speed up. Tar and dust deposited deep in the lung (black lung) are essentially irreversible once in, and no external agent washes them out. So what truly protects the lung is keeping the dirt from getting in (quit smoking, avoid second-hand smoke, N95 on smoggy days, indoor HEPA), not cleansing afterward. Drinking more water to thin mucus is real, but that's hydration, not 'lung cleansing'.
martineau-2017cazzola-2015-nac-copdnih-ods-vitamin-ajolliffe-2019-copd-d
Chapter 6
Breathing patterns + training
Breathing patterns + training
Breath regulation — humans have paid attention to breathing technique for 2500 years (yoga / Taoism / Wim Hof / asthma rehab). Let's look at what modern physiology has validated and what it has overturned.
Real physiological facts:
Slow breathing (~6 breaths/min) vs normal 12-16 breaths/min triggers vagal / parasympathetic dominance, raises heart rate variability (HRV), drops blood pressure by ~3-5 mmHg, and improves anxiety short-termNose vs mouth breathing: nose breathing humidifies, warms, filters, and releases nitric oxide: A small signal molecule from the vessel lining that relaxes the vessel-wall muscle so the vessel widens. from the sinuses, improving oxygenation; chronic mouth breathing in children causes abnormal facial development and narrowed jaw, with real evidence (a long series of studies from Guilleminault's group)Deep breathing relieves acute anxiety: by lowering PCO₂ (transient respiratory alkalosis) which mildly constricts cerebral blood flow, subjectively felt as 'calm'Diaphragmatic (belly) breathing is more efficient than chest breathing — taught in respiratory rehab, singing, and public speaking
Evidence-based breathing-training applications:
In asthma + COPD pulmonary rehab, pursed-lip breathing reduces airway collapse; breathing exercises (Buteyko among them) may improve quality of life, hyperventilation symptoms and lung function in adult asthma, but the Cochrane 2020 review rates that evidence from moderate down to very low — an adjunct, not a treatment, and it does not grade Buteyko on its ownFor chronic pain / anxiety / insomnia: 4-7-8, box breathing, Tummo and similar techniques have evidence for short-term subjective stress reduction, but the long-term clinical effect is weakPre-operative pulmonary training with incentive spirometry to reduce postoperative atelectasis is evidence-based first-line
The Wim Hof method (active hyperventilation + cold exposure + breath holding): some studies show short-term improvements in anti-inflammatory markers (Kox 2014 *PNAS* LPS endotoxin challenge), but never do it underwater, while driving, or at heights — hyperventilation drives CO₂ down, so during the breath hold the urge to breathe arrives late; you can be well on the way to hypoxic blackout and still not feel any need to inhale. It also does not cure asthma, long COVID, or chronic inflammation; no large RCTs support those claims.
What 'breath regulation' is genuinely worth doing seriously:
1. Nose breathing as the default, especially during sleep — check nasal airflow, and address nasal congestion if needed (turbinate surgery / allergy management)
2. Kids should not mouth-breathe asleep — screen early for OSA + adenoidal facies
3. Sedentary work: take 10 deep breaths once an hour — opens lung bases and reduces atelectasis
4. Build an aerobic base through exercise — more effective than any breathing app
5. Quit smoking, avoid second-hand smoke, clean indoor air — 100× the impact of any breathwork
So breathwork is an adjunct and a psychological-regulation tool, not a treatment.
Real physiological facts:
Slow breathing (~6 breaths/min) vs normal 12-16 breaths/min triggers vagal / parasympathetic dominance, raises heart rate variability (HRV), drops blood pressure by ~3-5 mmHg, and improves anxiety short-termNose vs mouth breathing: nose breathing humidifies, warms, filters, and releases nitric oxide: A small signal molecule from the vessel lining that relaxes the vessel-wall muscle so the vessel widens. from the sinuses, improving oxygenation; chronic mouth breathing in children causes abnormal facial development and narrowed jaw, with real evidence (a long series of studies from Guilleminault's group)Deep breathing relieves acute anxiety: by lowering PCO₂ (transient respiratory alkalosis) which mildly constricts cerebral blood flow, subjectively felt as 'calm'Diaphragmatic (belly) breathing is more efficient than chest breathing — taught in respiratory rehab, singing, and public speaking
Evidence-based breathing-training applications:
In asthma + COPD pulmonary rehab, pursed-lip breathing reduces airway collapse; breathing exercises (Buteyko among them) may improve quality of life, hyperventilation symptoms and lung function in adult asthma, but the Cochrane 2020 review rates that evidence from moderate down to very low — an adjunct, not a treatment, and it does not grade Buteyko on its ownFor chronic pain / anxiety / insomnia: 4-7-8, box breathing, Tummo and similar techniques have evidence for short-term subjective stress reduction, but the long-term clinical effect is weakPre-operative pulmonary training with incentive spirometry to reduce postoperative atelectasis is evidence-based first-line
The Wim Hof method (active hyperventilation + cold exposure + breath holding): some studies show short-term improvements in anti-inflammatory markers (Kox 2014 *PNAS* LPS endotoxin challenge), but never do it underwater, while driving, or at heights — hyperventilation drives CO₂ down, so during the breath hold the urge to breathe arrives late; you can be well on the way to hypoxic blackout and still not feel any need to inhale. It also does not cure asthma, long COVID, or chronic inflammation; no large RCTs support those claims.
What 'breath regulation' is genuinely worth doing seriously:
1. Nose breathing as the default, especially during sleep — check nasal airflow, and address nasal congestion if needed (turbinate surgery / allergy management)
2. Kids should not mouth-breathe asleep — screen early for OSA + adenoidal facies
3. Sedentary work: take 10 deep breaths once an hour — opens lung bases and reduces atelectasis
4. Build an aerobic base through exercise — more effective than any breathing app
5. Quit smoking, avoid second-hand smoke, clean indoor air — 100× the impact of any breathwork
So breathwork is an adjunct and a psychological-regulation tool, not a treatment.
Ventilation in exercise · why breathlessness isn't the lung hitting its limit
From rest to all-out exercise, minute ventilation can soar from about 6 L/min to 150–200 L/min, a 25-fold-plus increase — one of the widest-ranging regulated systems in the body. Seeing how it scales dissolves a common misconception.The two knobs are tidal volume (how deep each breath is) and respiratory rate (how many per minute). Early exercise mostly deepens breaths, tidal volume rising from 500 mL to 2–3 L; only at higher intensity does rate take over, climbing from 12–16 to 40–50 breaths/min. Interestingly, ventilation rises almost the instant exercise starts — earlier than CO₂ actually accumulates — driven partly by a feedforward command from the cerebral cortex plus muscle and joint receptors during movement, not just by waiting for chemical signals.
Further up is an inflection called the ventilatory threshold, roughly where lactate starts accumulating noticeably. When bicarbonate buffers lactate it releases extra CO₂, and ventilation suddenly jumps a notch — which is why past a certain intensity you feel disproportionately breathless. It ties into VO₂max and pace training, a very practical marker in endurance work.
That leads to the misconception: in most healthy people exercising to exhaustion, the limiting factor isn't the lung. Healthy lungs have large ventilatory reserve, arterial oxygen saturation stays near 100% even in hard exercise, and what actually caps out first is cardiac output and the muscles' capacity to take up and use oxygen. So an ordinary person training with a breathing app gains little for performance — what really moves the ceiling is cardiorespiratory endurance training itself (raising VO₂max, stroke volume, mitochondrial density).
Two groups are exceptions: elite endurance athletes' lungs can genuinely become the bottleneck (exercise-induced arterial hypoxemia), and patients with COPD, asthma, or interstitial lung disease, where the lung's mechanical or diffusion limits arrive early. For these two groups, respiratory muscle training and pulmonary rehab have targeted value.
References · 12
- Weibel, E. R. (1963). Morphometry of the Human Lung. Springer-Verlag. (Foundational measurement of alveolar surface area and bronchial tree.)
- West, J. B. (2017). Physiological effects of chronic hypoxia. New England Journal of Medicine, 376(20), 1965-1971. 10.1056/NEJMra1612008
- National Institutes of Health, Office of Dietary Supplements. (2021). Potassium — Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Potassium-HealthProfessional
- National Academies of Sciences, Engineering, and Medicine. (2019). Dietary Reference Intakes for Sodium and Potassium. National Academies Press. www.ncbi.nlm.nih.gov/books/NBK538102
- Semenza, G. L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell, 148(3), 399-408. 10.1016/j.cell.2012.01.021
- Kaelin, W. G., & Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell, 30(4), 393-402. 10.1016/j.molcel.2008.04.009
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global Strategy for the Diagnosis, Management, and Prevention of COPD: 2024 Report. goldcopd.org/2024-gold-report
- Jolliffe, D. A., Greenberg, L., Hooper, R. L., et al. (2017). Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. The Lancet Respiratory Medicine, 5(11), 881-890. 10.1016/S2213-2600(17)30306-5
- Burnett, R., Chen, H., Szyszkowicz, M., et al. (2018). Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. Proceedings of the National Academy of Sciences, 115(38), 9592-9597. 10.1073/pnas.1803222115
- Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006). Mortality in COPD: role of comorbidities. European Respiratory Journal, 28(6), 1245-1257. 10.1183/09031936.00133805
- Kox, M., van Eijk, L. T., Zwaag, J., van den Wildenberg, J., Sweep, F. C. G. J., van der Hoeven, J. G., & Pickkers, P. (2014). Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proceedings of the National Academy of Sciences, 111(20), 7379-7384. N=24 healthy men, endotoxaemia (LPS) challenge after training in the Wim Hof method. ⚠️ It says nothing about hyperventilation-breath-hold blackout or drowning; do not hang a water-safety claim on it. 10.1073/pnas.1322174111
- Santino, T. A., Chaves, G. S. S., Freitas, D. A., Fregonezi, G. A. F., & Mendonça, K. M. P. P. (2020). Breathing exercises for adults with asthma. Cochrane Database of Systematic Reviews, (3), CD001277. ⚠️ It covers breathing exercises as a class, not the Buteyko method specifically, and its certainty ratings run from moderate down to very low — so it does not support calling Buteyko B-level evidence. 10.1002/14651858.CD001277.pub4